You are here: All Products  > Transcenta OK’d to Start US Trials of MASP2 mAb for Kidney Disease

Transcenta OK’d to Start US Trials of MASP2 mAb for Kidney Disease

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days. 


Back to products